Kathy Giusti

Although not yet routine, many cancer centers have the technology to sequence some or all of a patient's cancer genome. This can provide massive amounts of valuable information about your cancer, including whether you have genetic mutations and other abnormalities for which new drugs are available.

Every time I go back to the Dana-Farber Cancer Institute to wait for my test results, and I wonder if I've relapsed or if I'm doing okay, I don't think about my company. I'm proud of everything we've done, but at the end of the day, it comes back to family. I'm still a wife, a mom, a sister - all of those things.

I want to tell mayors, county chiefs and heads of big companies: don't just chase GDP growth; don't chase the biggest profits at the expense of our children and grandchildren and at the cost of sacrificing our ecological environment.